Lv11
50 积分 2025-09-12 加入
Overcoming ABC transporter-mediated multidrug resistance: Molecular mechanisms and novel therapeutic drug strategies
16天前
已完结
FOLFOXIRI/bevacizumab versus doublets/bevacizumab as initial therapy of unresectable liver-only, right-sided and/or RAS or BRAF mutated metastatic colorectal cancer: An individual patient data-based pooled analysis of randomized trials
17天前
已完结
Molecular mechanism for a role of SHP2 in epidermal growth factor receptor signaling
8个月前
已完结
Molecular mechanism for a role of SHP2 in epidermal growth factor receptor signaling
8个月前
已关闭
KRAS G12C in advanced NSCLC: Prevalence, co-mutations, and testing
8个月前
已完结
Targeting KRAS in cancer
9个月前
已完结
皖公网安备34019202002308
